Bank of Montreal
DYN icon

Bank of Montreal’s Dyne Therapeutics DYN Stock Holding History

Bank of Montreal’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-41,304
Closed -$290 – 4141
2022
Q2 		$290 Buy
+41,304
New +$285K ﹤0.01% 3027
2021
Q2 		– Sell
-479
Closed -$8K – 4000
2021
Q1 		$8K Sell
479
-1,750
-79% -$33.9K ﹤0.01% 4446
2020
Q4 		$60K Buy
+2,229
New +$44.1K ﹤0.01% 3860

Other funds holding DYN

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bank of Montreal's DYN Position: Q3 2022 in Review

Bank of Montreal sold out of Dyne Therapeutics (DYN) in Q3 2022, closing a stake of 41,304 shares — an estimated $290 sold.

Bank of Montreal first reported a position in DYN in Q4 2020 and held it in 3 quarters. The position peaked at $60K in Q4 2020. 102 funds tracked by Wall St. Rank hold DYN as of Q3 2022.

  • Bank of Montreal reported no remaining Dyne Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Bank of Montreal sold 41,304 Dyne Therapeutics shares in Q3 2022, an estimated $290.
  • Bank of Montreal first reported a position in Dyne Therapeutics in Q4 2020 and held it in 3 quarters.
  • Bank of Montreal's Dyne Therapeutics position peaked at $60K in Q4 2020.
  • 102 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.